Trials / Withdrawn
WithdrawnNCT03309514
Transplantation of Neural Stem Cell-Derived Neurons for Parkinson's Disease
Clinical Investigation of Transplantation of Neural Stem Cell-derived Neurons for the Treatment of Parkinson's Disease
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- NeuroGeneration · Industry
- Sex
- All
- Age
- 35 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective study to demonstrate the safety and efficacy of differentiated neurons-derived from adult CNS progenitors cells transplanted in selected patients with Parkinson's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Intracerebral microinjections | Stereotactic delivery of cell suspension into basal ganglia structures |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2023-12-31
- Completion
- 2024-06-30
- First posted
- 2017-10-13
- Last updated
- 2022-04-12
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03309514. Inclusion in this directory is not an endorsement.